Advances in Clinical and Experimental Medicine · 2020 · 14 citations · 18 references
MedicineCardiologyGeneticsCardiovascular GeneticsHuman GeneticsMedical GeneticsCardiovascular DiseaseCardiovascular Disease PreventionCardiovascular RiskCoronary Artery DiseaseGenetic RiskGenetic SusceptibilityAtherosclerosis GeneticsAtherosclerotic ProgressionAtherosclerotic Risk AssessmentCase-control Study DesignCoronary Artery Disease GeneticsDipeptidyl PeptidasesGenetic PolymorphismsSingle-nucleotide Polymorphisms
BACKGROUND: In recent years, considerable effort has been devoted to identifying genes that contribute to the risk of coronary artery disease (CAD). Genetic factors can be used to identify individuals who have additional genetic risks. Genetic variations might contribute to cardiovascular disease differentially in men and women. Dipeptidyl peptidase-4 (DPP-4) may be involved in the development of atherosclerotic diseases. OBJECTIVES: To examine the associations between genetic variations of DPP-4 in men and women with CAD. MATERIAL AND METHODS: In this case-control study, blood samples of patients with angiographically documented CAD and of those without CAD were collected. We focused on the DPP-4 gene (rs7608798 and rs3788979 polymorphisms) to assess the association of single nucleotide polymorphisms (SNPs) and the risk of CAD. RESULTS: We identified 1 SNP (rs3788979) that was significantly related to angiographic CAD in women (odds ratio (OR) = 2.437; p = 0.019). Moreover, the SNP (rs7608798) seemed to have a protective effect (OR = 0.291; p = 0.032). We did not find an association between CAD risk factors and DPP-4 polymorphisms. Our study is the first to demonstrate that CAD pathogenesis is influenced by gender differences in polymorphisms in the DPP-4 gene. CONCLUSIONS: This study provides new information on the association of DPP-4 polymorphisms with the risk of CAD in the Taiwanese population, especially in women. Further studies should be performed to verify this association.
18
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Jennifer B. Green, M. Angelyn Bethel, Paul W. Armstrong et al. · New England Journal of Medicine · 2015 · 2.6K citations · Full text